Literature DB >> 22381425

Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.

Mathias C Brandt1, Felix Mahfoud, Sara Reda, Stephan H Schirmer, Erland Erdmann, Michael Böhm, Uta C Hoppe.   

Abstract

OBJECTIVES: This study investigated the effect of catheter-based renal sympathetic denervation (RD) on left ventricular hypertrophy (LVH) and systolic and diastolic function in patients with resistant hypertension.
BACKGROUND: LVH and diastolic dysfunction are associated with elevated sympathetic activity and increased morbidity and mortality. The effect of RD on LVH and LV function is unclear.
METHODS: Forty-six patients underwent bilateral RD, and 18 patients served as controls. Transthoracic echocardiography was performed at baseline, and after 1 month and 6 months.
RESULTS: Besides reduction of systolic and diastolic blood pressure (-22.5/-7.2 mm Hg at 1 month and -27.8/-8.8 mm Hg at 6 months, p < 0.001 at each time point), RD significantly reduced mean interventricular septum thickness from 14.1 ± 1.9 mm to 13.4 ± 2.1 mm and 12.5 ± 1.4 mm (p = 0.007), and LV mass index from 53.9 ± 15.6 g/m(2.7) (112.4 ± 33.9 g/m(2)) to 47.0 ± 14.2 g/m(2.7) (103.6 ± 30.5 g/m(2)) and 44.7 ± 14.9 g/m(2.7) (94.9 ± 29.8 g/m(2)) (p < 0.001) at 1 month and 6 months, respectively. The mitral valve lateral E/E' decreased after RD from 9.9 ± 4.0 to 7.9 ± 2.2 at 1 month and 7.4 ± 2.7 at 6 months (p < 0.001), indicating reduction of LV filling pressures. Isovolumic relaxation time shortened (baseline 109.1 ± 21.7 ms vs. 85.6 ± 24.4 ms at 6 months, p = 0.006), whereas ejection fraction significantly increased after RD (baseline: 63.1 ± 8.1% vs. 70.1 ± 11.5% at 6 months, p < 0.001). No significant changes were obtained in control patients.
CONCLUSIONS: Besides the known effect on blood pressure, our study showed for the first time that RD significantly reduces LV mass and improves diastolic function, which might have important prognostic implications in patients with resistant hypertension at high cardiovascular risk. Copyright Â
© 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22381425     DOI: 10.1016/j.jacc.2011.11.034

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  150 in total

1.  Hypertension. Cardiac effects of renal denervation.

Authors:  Gregory B Lim
Journal:  Nat Rev Cardiol       Date:  2012-03-20       Impact factor: 32.419

2.  Cardiovascular disease: Stenting in renovascular disease--good news for the heart?

Authors:  Lars Christian Rump; Lorenz Sellin
Journal:  Nat Rev Nephrol       Date:  2012-05-29       Impact factor: 28.314

3.  Hypertension: Renal denervation in chronic kidney disease.

Authors:  Peter J Blankestijn; Jaap A Joles
Journal:  Nat Rev Nephrol       Date:  2012-07-03       Impact factor: 28.314

4.  Autonomic Dysregulation as a Therapeutic Target for Acute HF.

Authors:  Anju Bhardwaj; Mark E Dunlap
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-10

Review 5.  Reductions of left ventricular mass and atrial size following renal denervation: a meta-analysis.

Authors:  Dasheng Lu; Kai Wang; Qian Liu; Shengchan Wang; Qi Zhang; Qijun Shan
Journal:  Clin Res Cardiol       Date:  2016-02-02       Impact factor: 5.460

Review 6.  Renal sympathetic denervation: applications in hypertension and beyond.

Authors:  Michael Böhm; Dominik Linz; Daniel Urban; Felix Mahfoud; Christian Ukena
Journal:  Nat Rev Cardiol       Date:  2013-06-18       Impact factor: 32.419

Review 7.  Review of the state of renal nerve ablation for patients with severe and resistant hypertension.

Authors:  Vinay Gulati; William B White
Journal:  J Am Soc Hypertens       Date:  2013-08-15

8.  Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry.

Authors:  Britta Vogel; Michael Kirchberger; Martin Zeier; Felicitas Stoll; Benjamin Meder; Daniel Saure; Martin Andrassy; Oliver J Mueller; Stefan Hardt; Vedat Schwenger; Anna Strothmeyer; Hugo A Katus; Erwin Blessing
Journal:  Clin Res Cardiol       Date:  2013-10-15       Impact factor: 5.460

9.  Early reduction of therapy-resistant hypertension in a patient after single-sided renal denervation approach.

Authors:  Marco R Schroeter; Michael Koziolek
Journal:  Clin Res Cardiol       Date:  2013-11-19       Impact factor: 5.460

10.  [Diastolic heart failure: heart failure with preserved ejection fraction].

Authors:  P Dovjak
Journal:  Z Gerontol Geriatr       Date:  2013-01       Impact factor: 1.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.